Subscribe to RSS - insulet


Insulet grows revenues in Q4


BEDFORD, Mass. – Insulet’s revenues in the fourth quarter of 2013 were $68.5 million, an increase of 19% over the same period in 2012, the company announced Feb. 27.

In brief: Providers merge, neb-meds reverse course


HIGH POINT, N.C. – Advanced Home Care has merged with WellStar HME & Infusion to expand its footprint in Georgia, the provider has announced.

Insulet, Amgen form agreement


BEDFORD, Mass. – Under a five-year agreement announced Dec. 10, Insulet will supply biotech company Amgen with a device to deliver medications.

In brief: NGS details reasons for denials, TiLite shakes up representation


INDIANAPOLIS – Prior authorization requests submitted as part of the PMD demo are being denied because of conflicting information in face-to-face exams and other medical records, and insufficient face-to-face exam information, National Government Services (NGS) announced in a recent bulletin.

Insulet posts third quarter results


BEDFORD, Mass. – Insulet’s revenues reached $61.1 million in the third quarter compared to $54.8 million during the same period last year, a 12% increase, the company announced Nov. 7.

People news: Howard Zisser, Josh Renihan, Dean Kamen


BEDFORD, Mass. – Howard Zisser is the first medical director at Insulet Corp., the company announced Oct. 17. An expert on diabetes, Zisser has researched new therapies for Type 1, Type 2 and gestational diabetes.

In brief: Phone calls improve compliance, provider runs for statehouse


BARCELONA, Spain – CPAP patients who received follow-up phone calls were 10% more compliant, according to a French study.

Insulet, Medtronic settle lawsuit


BEDFORD, Mass. – Insulet has reached a settlement with Medtronic MiniMed in a pending lawsuit over patent infringement, according to a Sept. 25 news release.

Insulet hits financial milestone


BEDFORD, Mass. – Insulin pump maker Insulet reported revenues of $60.1 million for the second quarter ended June 30, 2013, an 18% increase compared to the same period last year. Gross profit was $26.8 million, compared to $22.3 million.

Revenues climb at Insulet


BEDFORD, Mass. – Insulet, a provider of insulin pumps for patients with diabetes, reported $58.7 million in revenues for the fourth quarter of 2012, a 23% increase over the same period in 2011. It reported net losses of $10.2 million vs. $14.3 million.